Jeffrey Wong

3PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 26, 2025
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.

Jung Sun Kim, Jeffrey Wong, San-Chi Chen

|May 15, 2023
Evolution of systemic therapy for advanced HCC patients: Did we make progress in 2022?

Jeffrey Sum Lung Wong, Roland Leung, Tan To Cheung

|Feb 10, 2021
Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.

Jeffrey Sum Lung Wong, Gerry Gin Wai Kwok, Vikki Tang

Pageof 1